Therefore, after showing that the combination of selinexor and ibrutinib restrains tumor growth and prolongs mice survival, and since both drugs are able to inhibit BTK, we hypothesized that these drugs could also cooperate to modify the innate immune response in PCNSL. Here, BTK is linked to primary central nervous system lymphoma.